ABACAVIR , LAMIVUDINE AND ZIDOVUDINE (ABACAVIR, LAMIVUDINE AND ZIDOVUDINE) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ABACAVIR , LAMIVUDINE AND ZIDOVUDINE

What is the Trade Name for ABACAVIR , LAMIVUDINE AND ZIDOVUDINE

ABACAVIR, LAMIVUDINE AND ZIDOVUDINE

What is the Indication for ABACAVIR , LAMIVUDINE AND ZIDOVUDINE

  • 1 INDICATIONS AND USAGE Abacavir, lamivudine and zidovudine tablet, a combination of abacavir, lamivudine, and zidovudine, each nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.( 1 ) Abacavir, lamivudine and zidovudine tablet is indicated in combination with other antiretrovirals or alone for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Limitations of Use: Limited data exist on the use of abacavir, lamivudine and zidovudine tablets alone in patients with higher baseline viral load levels (greater than 100,000 copies per mL) [see CLINICAL STUDIES ( 14 )] .

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]